nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxymesterone—SHBG—osteoporosis	0.201	0.597	CbGaD
Fluoxymesterone—ESR1—osteoporosis	0.136	0.403	CbGaD
Fluoxymesterone—SHBG—Estropipate—osteoporosis	0.0733	0.186	CbGbCtD
Fluoxymesterone—Danazol—Ethinyl Estradiol—osteoporosis	0.0605	0.309	CrCrCtD
Fluoxymesterone—ESR1—Estropipate—osteoporosis	0.053	0.134	CbGbCtD
Fluoxymesterone—Norethindrone—Ethinyl Estradiol—osteoporosis	0.0526	0.269	CrCrCtD
Fluoxymesterone—AR—Ergocalciferol—osteoporosis	0.049	0.124	CbGbCtD
Fluoxymesterone—SHBG—Ethinyl Estradiol—osteoporosis	0.0473	0.12	CbGbCtD
Fluoxymesterone—Methyltestosterone—Ethinyl Estradiol—osteoporosis	0.0432	0.221	CrCrCtD
Fluoxymesterone—Testosterone—Estradiol—osteoporosis	0.0394	0.201	CrCrCtD
Fluoxymesterone—ESR1—Raloxifene—osteoporosis	0.0354	0.0895	CbGbCtD
Fluoxymesterone—ESR1—Ethinyl Estradiol—osteoporosis	0.0342	0.0864	CbGbCtD
Fluoxymesterone—SHBG—Estradiol—osteoporosis	0.0305	0.0771	CbGbCtD
Fluoxymesterone—AR—Estradiol—osteoporosis	0.0255	0.0645	CbGbCtD
Fluoxymesterone—ESR1—Conjugated Estrogens—osteoporosis	0.0251	0.0635	CbGbCtD
Fluoxymesterone—ESR1—Estradiol—osteoporosis	0.022	0.0557	CbGbCtD
Fluoxymesterone—Clotting—Conjugated Estrogens—osteoporosis	0.00139	0.0386	CcSEcCtD
Fluoxymesterone—Hirsutism—Estropipate—osteoporosis	0.00129	0.0359	CcSEcCtD
Fluoxymesterone—Clotting—Estradiol—osteoporosis	0.00111	0.0309	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Estropipate—osteoporosis	0.000855	0.0238	CcSEcCtD
Fluoxymesterone—Jaundice cholestatic—Estropipate—osteoporosis	0.000855	0.0238	CcSEcCtD
Fluoxymesterone—Hirsutism—Conjugated Estrogens—osteoporosis	0.000854	0.0237	CcSEcCtD
Fluoxymesterone—ESR1—periosteum—osteoporosis	0.000733	0.368	CbGeAlD
Fluoxymesterone—Coagulopathy—Pamidronate—osteoporosis	0.000725	0.0201	CcSEcCtD
Fluoxymesterone—Menstruation irregular—Estradiol—osteoporosis	0.000718	0.0199	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Ethinyl Estradiol—osteoporosis	0.000693	0.0193	CcSEcCtD
Fluoxymesterone—Hirsutism—Estradiol—osteoporosis	0.000684	0.019	CcSEcCtD
Fluoxymesterone—Coagulopathy—Zoledronate—osteoporosis	0.000662	0.0184	CcSEcCtD
Fluoxymesterone—PRLR—uterus—osteoporosis	0.000659	0.33	CbGeAlD
Fluoxymesterone—Coagulopathy—Conjugated Estrogens—osteoporosis	0.000638	0.0177	CcSEcCtD
Fluoxymesterone—Jaundice cholestatic—Conjugated Estrogens—osteoporosis	0.000565	0.0157	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Conjugated Estrogens—osteoporosis	0.000565	0.0157	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Estropipate—osteoporosis	0.000563	0.0157	CcSEcCtD
Fluoxymesterone—Libido decreased—Calcitriol—osteoporosis	0.000552	0.0153	CcSEcCtD
Fluoxymesterone—Coagulopathy—Estradiol—osteoporosis	0.00051	0.0142	CcSEcCtD
Fluoxymesterone—Disturbance in sexual arousal—Calcitriol—osteoporosis	0.000508	0.0141	CcSEcCtD
Fluoxymesterone—Libido decreased—Ethinyl Estradiol—osteoporosis	0.000477	0.0132	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Estradiol—osteoporosis	0.000452	0.0126	CcSEcCtD
Fluoxymesterone—Jaundice cholestatic—Estradiol—osteoporosis	0.000452	0.0126	CcSEcCtD
Fluoxymesterone—Disturbance in sexual arousal—Ethinyl Estradiol—osteoporosis	0.000439	0.0122	CcSEcCtD
Fluoxymesterone—Paraesthesia—Calcium Acetate—osteoporosis	0.000424	0.0118	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Pamidronate—osteoporosis	0.000423	0.0118	CcSEcCtD
Fluoxymesterone—Alopecia—Etidronic acid—osteoporosis	0.000385	0.0107	CcSEcCtD
Fluoxymesterone—Haemoglobin—Alendronate—osteoporosis	0.000373	0.0104	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Conjugated Estrogens—osteoporosis	0.000372	0.0103	CcSEcCtD
Fluoxymesterone—Haemorrhage—Alendronate—osteoporosis	0.000372	0.0103	CcSEcCtD
Fluoxymesterone—Haemoglobin—Ibandronate—osteoporosis	0.000364	0.0101	CcSEcCtD
Fluoxymesterone—Haemorrhage—Ibandronate—osteoporosis	0.000362	0.0101	CcSEcCtD
Fluoxymesterone—Haemoglobin—Calcitriol—osteoporosis	0.000356	0.00989	CcSEcCtD
Fluoxymesterone—Gynaecomastia—Estradiol—osteoporosis	0.000355	0.00988	CcSEcCtD
Fluoxymesterone—Haemorrhage—Calcitriol—osteoporosis	0.000354	0.00984	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Calcium Acetate—osteoporosis	0.000348	0.00966	CcSEcCtD
Fluoxymesterone—Alopecia—Estropipate—osteoporosis	0.000333	0.00926	CcSEcCtD
Fluoxymesterone—Alopecia—Alendronate—osteoporosis	0.000328	0.00912	CcSEcCtD
Fluoxymesterone—Alopecia—Ibandronate—osteoporosis	0.00032	0.00888	CcSEcCtD
Fluoxymesterone—Libido decreased—Estradiol—osteoporosis	0.000311	0.00864	CcSEcCtD
Fluoxymesterone—Haemoglobin—Ethinyl Estradiol—osteoporosis	0.000307	0.00854	CcSEcCtD
Fluoxymesterone—AR—Notch-mediated HES/HEY network—BGLAP—osteoporosis	0.000307	0.00968	CbGpPWpGaD
Fluoxymesterone—Haemorrhage—Ethinyl Estradiol—osteoporosis	0.000306	0.0085	CcSEcCtD
Fluoxymesterone—Haemoglobin—Risedronate—osteoporosis	0.0003	0.00833	CcSEcCtD
Fluoxymesterone—Haemorrhage—Risedronate—osteoporosis	0.000298	0.00828	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Estradiol—osteoporosis	0.000298	0.00828	CcSEcCtD
Fluoxymesterone—AR—Nuclear Receptors—ESR2—osteoporosis	0.000291	0.00919	CbGpPWpGaD
Fluoxymesterone—PRLR—Adipogenesis—IRS2—osteoporosis	0.00029	0.00914	CbGpPWpGaD
Fluoxymesterone—Disturbance in sexual arousal—Estradiol—osteoporosis	0.000286	0.00795	CcSEcCtD
Fluoxymesterone—Haemoglobin—Pamidronate—osteoporosis	0.000285	0.00792	CcSEcCtD
Fluoxymesterone—PRLR—Adipogenesis—LEP—osteoporosis	0.000284	0.00895	CbGpPWpGaD
Fluoxymesterone—Haemorrhage—Pamidronate—osteoporosis	0.000283	0.00788	CcSEcCtD
Fluoxymesterone—Nausea—Calcium Acetate—osteoporosis	0.00028	0.00779	CcSEcCtD
Fluoxymesterone—Anxiety—Estropipate—osteoporosis	0.000279	0.00774	CcSEcCtD
Fluoxymesterone—Paraesthesia—Etidronic acid—osteoporosis	0.000278	0.00773	CcSEcCtD
Fluoxymesterone—Testolactone—CYP19A1—osteoporosis	0.000272	0.127	CrCbGaD
Fluoxymesterone—Alopecia—Ethinyl Estradiol—osteoporosis	0.00027	0.00751	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Estropipate—osteoporosis	0.000268	0.00745	CcSEcCtD
Fluoxymesterone—Anxiety—Ibandronate—osteoporosis	0.000267	0.00742	CcSEcCtD
Fluoxymesterone—Anxiety—Calcitriol—osteoporosis	0.000262	0.00727	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Ibandronate—osteoporosis	0.000257	0.00714	CcSEcCtD
Fluoxymesterone—PRLR—Signaling by ERBB4—IRS2—osteoporosis	0.000256	0.00807	CbGpPWpGaD
Fluoxymesterone—PRLR—Adipogenesis—IRS1—osteoporosis	0.000253	0.00798	CbGpPWpGaD
Fluoxymesterone—Anaphylactic shock—Calcitriol—osteoporosis	0.000252	0.00699	CcSEcCtD
Fluoxymesterone—Alopecia—Pamidronate—osteoporosis	0.00025	0.00696	CcSEcCtD
Fluoxymesterone—Nausea—Ergocalciferol—osteoporosis	0.000248	0.00688	CcSEcCtD
Fluoxymesterone—Paraesthesia—Estropipate—osteoporosis	0.000241	0.00669	CcSEcCtD
Fluoxymesterone—PRLR—Signaling by ERBB4—ESR1—osteoporosis	0.000239	0.00754	CbGpPWpGaD
Fluoxymesterone—PRLR—Adipogenesis—IGF1—osteoporosis	0.000235	0.00739	CbGpPWpGaD
Fluoxymesterone—AR—Nuclear Receptors—VDR—osteoporosis	0.000231	0.00729	CbGpPWpGaD
Fluoxymesterone—Paraesthesia—Ibandronate—osteoporosis	0.000231	0.00641	CcSEcCtD
Fluoxymesterone—AR—Nuclear Receptor transcription pathway—ESR2—osteoporosis	0.00023	0.00726	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—COL1A2—osteoporosis	0.000229	0.00723	CbGpPWpGaD
Fluoxymesterone—Alopecia—Zoledronate—osteoporosis	0.000229	0.00636	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Etidronic acid—osteoporosis	0.000228	0.00634	CcSEcCtD
Fluoxymesterone—Anxiety—Ethinyl Estradiol—osteoporosis	0.000226	0.00628	CcSEcCtD
Fluoxymesterone—ESR1—Nuclear Receptors—ESR2—osteoporosis	0.000224	0.00708	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—IRS1—osteoporosis	0.000223	0.00704	CbGpPWpGaD
Fluoxymesterone—NR3C1—Transcription factor regulation in adipogenesis—IRS2—osteoporosis	0.000222	0.007	CbGpPWpGaD
Fluoxymesterone—NR3C1—Nuclear Receptors—ESR2—osteoporosis	0.000221	0.00697	CbGpPWpGaD
Fluoxymesterone—Alopecia—Conjugated Estrogens—osteoporosis	0.00022	0.00612	CcSEcCtD
Fluoxymesterone—Anxiety—Risedronate—osteoporosis	0.00022	0.00612	CcSEcCtD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—DKK1—osteoporosis	0.000218	0.00689	CbGpPWpGaD
Fluoxymesterone—NR3C1—Transcription factor regulation in adipogenesis—LEP—osteoporosis	0.000217	0.00685	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—ESR2—osteoporosis	0.000211	0.00666	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—IL6R—osteoporosis	0.00021	0.00662	CbGpPWpGaD
Fluoxymesterone—Anxiety—Pamidronate—osteoporosis	0.000209	0.00582	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Pamidronate—osteoporosis	0.000201	0.0056	CcSEcCtD
Fluoxymesterone—Haemoglobin—Estradiol—osteoporosis	0.000201	0.00557	CcSEcCtD
Fluoxymesterone—Haemorrhage—Estradiol—osteoporosis	0.0002	0.00554	CcSEcCtD
Fluoxymesterone—ESR1—AP-1 transcription factor network—COL1A2—osteoporosis	0.000199	0.00626	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Estropipate—osteoporosis	0.000197	0.00549	CcSEcCtD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—COL1A2—osteoporosis	0.000196	0.00617	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Alendronate—osteoporosis	0.000195	0.0054	CcSEcCtD
Fluoxymesterone—Headache—Etidronic acid—osteoporosis	0.000194	0.00539	CcSEcCtD
Fluoxymesterone—NR3C1—Transcription factor regulation in adipogenesis—IRS1—osteoporosis	0.000194	0.00611	CbGpPWpGaD
Fluoxymesterone—Anxiety—Zoledronate—osteoporosis	0.000191	0.00531	CcSEcCtD
Fluoxymesterone—Paraesthesia—Risedronate—osteoporosis	0.00019	0.00529	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Ibandronate—osteoporosis	0.000189	0.00526	CcSEcCtD
Fluoxymesterone—NR3C1—Endoderm Differentiation—DKK1—osteoporosis	0.000189	0.00595	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—NFATC1—osteoporosis	0.000189	0.00595	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—NFATC1—osteoporosis	0.000186	0.00586	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Calcitriol—osteoporosis	0.000185	0.00515	CcSEcCtD
Fluoxymesterone—Anxiety—Conjugated Estrogens—osteoporosis	0.000184	0.00512	CcSEcCtD
Fluoxymesterone—Nausea—Etidronic acid—osteoporosis	0.000184	0.00511	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Zoledronate—osteoporosis	0.000184	0.00511	CcSEcCtD
Fluoxymesterone—AR—Nuclear Receptor transcription pathway—VDR—osteoporosis	0.000183	0.00576	CbGpPWpGaD
Fluoxymesterone—Paraesthesia—Pamidronate—osteoporosis	0.000181	0.00502	CcSEcCtD
Fluoxymesterone—Danazol—SHBG—osteoporosis	0.000178	0.083	CrCbGaD
Fluoxymesterone—ESR1—Nuclear Receptors—VDR—osteoporosis	0.000178	0.00562	CbGpPWpGaD
Fluoxymesterone—ESR1—Nuclear Receptor transcription pathway—ESR2—osteoporosis	0.000177	0.00559	CbGpPWpGaD
Fluoxymesterone—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000177	0.00492	CcSEcCtD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—COL1A2—osteoporosis	0.000177	0.00557	CbGpPWpGaD
Fluoxymesterone—AR—Nuclear Receptors—ESR1—osteoporosis	0.000177	0.00557	CbGpPWpGaD
Fluoxymesterone—Alopecia—Estradiol—osteoporosis	0.000176	0.0049	CcSEcCtD
Fluoxymesterone—NR3C1—Nuclear Receptors—VDR—osteoporosis	0.000175	0.00553	CbGpPWpGaD
Fluoxymesterone—NR3C1—Nuclear Receptor transcription pathway—ESR2—osteoporosis	0.000175	0.00551	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—COL1A2—osteoporosis	0.000174	0.00549	CbGpPWpGaD
Fluoxymesterone—Spironolactone—SHBG—osteoporosis	0.000171	0.0795	CrCbGaD
Fluoxymesterone—Headache—Estropipate—osteoporosis	0.000168	0.00467	CcSEcCtD
Fluoxymesterone—Headache—Alendronate—osteoporosis	0.000165	0.0046	CcSEcCtD
Fluoxymesterone—Paraesthesia—Zoledronate—osteoporosis	0.000165	0.00459	CcSEcCtD
Fluoxymesterone—NR3C1—Endoderm Differentiation—PTHLH—osteoporosis	0.000164	0.00518	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—NFATC1—osteoporosis	0.000164	0.00516	CbGpPWpGaD
Fluoxymesterone—Headache—Raloxifene—osteoporosis	0.000163	0.00452	CcSEcCtD
Fluoxymesterone—Headache—Ibandronate—osteoporosis	0.000161	0.00447	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00016	0.00445	CcSEcCtD
Fluoxymesterone—Medroxyprogesterone Acetate—SHBG—osteoporosis	0.00016	0.0745	CrCbGaD
Fluoxymesterone—Nausea—Estropipate—osteoporosis	0.000159	0.00442	CcSEcCtD
Fluoxymesterone—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000159	0.00442	CcSEcCtD
Fluoxymesterone—Norethindrone—SHBG—osteoporosis	0.000159	0.0738	CrCbGaD
Fluoxymesterone—Headache—Calcitriol—osteoporosis	0.000158	0.00438	CcSEcCtD
Fluoxymesterone—AR—FOXA1 transcription factor network—ESR1—osteoporosis	0.000157	0.00495	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—IRS2—osteoporosis	0.000157	0.00495	CbGpPWpGaD
Fluoxymesterone—Nausea—Alendronate—osteoporosis	0.000157	0.00436	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Risedronate—osteoporosis	0.000156	0.00434	CcSEcCtD
Fluoxymesterone—Nausea—Raloxifene—osteoporosis	0.000154	0.00429	CcSEcCtD
Fluoxymesterone—PRLR—Signaling Pathways—SOST—osteoporosis	0.000154	0.00485	CbGpPWpGaD
Fluoxymesterone—Nausea—Ibandronate—osteoporosis	0.000153	0.00424	CcSEcCtD
Fluoxymesterone—Methyltestosterone—SHBG—osteoporosis	0.000151	0.0701	CrCbGaD
Fluoxymesterone—Nausea—Calcitriol—osteoporosis	0.000149	0.00415	CcSEcCtD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—BGLAP—osteoporosis	0.000149	0.00471	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Pamidronate—osteoporosis	0.000148	0.00412	CcSEcCtD
Fluoxymesterone—ESR1—Validated nuclear estrogen receptor alpha network—ESR2—osteoporosis	0.000148	0.00466	CbGpPWpGaD
Fluoxymesterone—Anxiety—Estradiol—osteoporosis	0.000147	0.00409	CcSEcCtD
Fluoxymesterone—PRLR—Immune System—IRAK3—osteoporosis	0.000145	0.00458	CbGpPWpGaD
Fluoxymesterone—SHBG—uterus—osteoporosis	0.000142	0.0713	CbGeAlD
Fluoxymesterone—Anaphylactic shock—Estradiol—osteoporosis	0.000142	0.00394	CcSEcCtD
Fluoxymesterone—ESR1—Nuclear Receptor transcription pathway—VDR—osteoporosis	0.000141	0.00444	CbGpPWpGaD
Fluoxymesterone—PRLR—Adipogenesis—TGFB1—osteoporosis	0.000141	0.00443	CbGpPWpGaD
Fluoxymesterone—AR—Nuclear Receptor transcription pathway—ESR1—osteoporosis	0.00014	0.0044	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PTH1R—osteoporosis	0.000139	0.00438	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CALCR—osteoporosis	0.000139	0.00438	CbGpPWpGaD
Fluoxymesterone—NR3C1—Nuclear Receptor transcription pathway—VDR—osteoporosis	0.000139	0.00437	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—IRS1—osteoporosis	0.000137	0.00432	CbGpPWpGaD
Fluoxymesterone—Headache—Ethinyl Estradiol—osteoporosis	0.000136	0.00378	CcSEcCtD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—GAPDH—osteoporosis	0.000136	0.00428	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—RAP1A—osteoporosis	0.000136	0.00428	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Zoledronate—osteoporosis	0.000136	0.00377	CcSEcCtD
Fluoxymesterone—NR3C1—Signaling events mediated by HDAC Class II—ESR1—osteoporosis	0.000134	0.00423	CbGpPWpGaD
Fluoxymesterone—NR3C1—Nuclear Receptors—ESR1—osteoporosis	0.000134	0.00423	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—ACTG1—osteoporosis	0.000133	0.00419	CbGpPWpGaD
Fluoxymesterone—Headache—Risedronate—osteoporosis	0.000133	0.00369	CcSEcCtD
Fluoxymesterone—PRLR—Adipogenesis—TNF—osteoporosis	0.000131	0.00414	CbGpPWpGaD
Fluoxymesterone—Danazol—CYP19A1—osteoporosis	0.000131	0.0609	CrCbGaD
Fluoxymesterone—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00013	0.00363	CcSEcCtD
Fluoxymesterone—Nausea—Ethinyl Estradiol—osteoporosis	0.000129	0.00359	CcSEcCtD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—IL6R—osteoporosis	0.000129	0.00406	CbGpPWpGaD
Fluoxymesterone—Paraesthesia—Estradiol—osteoporosis	0.000127	0.00354	CcSEcCtD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—VDR—osteoporosis	0.000126	0.00398	CbGpPWpGaD
Fluoxymesterone—Headache—Pamidronate—osteoporosis	0.000126	0.00351	CcSEcCtD
Fluoxymesterone—Nausea—Risedronate—osteoporosis	0.000126	0.0035	CcSEcCtD
Fluoxymesterone—SHBG—bone marrow—osteoporosis	0.000121	0.0606	CbGeAlD
Fluoxymesterone—Danazol—ESR1—osteoporosis	0.00012	0.056	CrCbGaD
Fluoxymesterone—Nausea—Pamidronate—osteoporosis	0.00012	0.00332	CcSEcCtD
Fluoxymesterone—Headache—Zoledronate—osteoporosis	0.000115	0.0032	CcSEcCtD
Fluoxymesterone—Hydrocortisone—SHBG—osteoporosis	0.000113	0.0528	CrCbGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	0.000113	0.00355	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—RAP1A—osteoporosis	0.000111	0.0035	CbGpPWpGaD
Fluoxymesterone—Headache—Conjugated Estrogens—osteoporosis	0.000111	0.00308	CcSEcCtD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—IGF1—osteoporosis	0.000111	0.0035	CbGpPWpGaD
Fluoxymesterone—Methyltestosterone—CYP19A1—osteoporosis	0.000111	0.0515	CrCbGaD
Fluoxymesterone—PRLR—Signaling Pathways—MGLL—osteoporosis	0.00011	0.00348	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CTSK—osteoporosis	0.00011	0.00347	CbGpPWpGaD
Fluoxymesterone—Nausea—Zoledronate—osteoporosis	0.000109	0.00304	CcSEcCtD
Fluoxymesterone—PRLR—Immune System—NFATC1—osteoporosis	0.000108	0.00341	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—WNT1—osteoporosis	0.000108	0.00341	CbGpPWpGaD
Fluoxymesterone—Medroxyprogesterone Acetate—ESR1—osteoporosis	0.000108	0.0503	CrCbGaD
Fluoxymesterone—PRLR—Signaling Pathways—LRP5—osteoporosis	0.000108	0.0034	CbGpPWpGaD
Fluoxymesterone—Betamethasone—CYP19A1—osteoporosis	0.000107	0.0496	CrCbGaD
Fluoxymesterone—PRLR—Adipogenesis—IL6—osteoporosis	0.000106	0.00334	CbGpPWpGaD
Fluoxymesterone—NR3C1—Nuclear Receptor transcription pathway—ESR1—osteoporosis	0.000106	0.00334	CbGpPWpGaD
Fluoxymesterone—Nausea—Conjugated Estrogens—osteoporosis	0.000105	0.00292	CcSEcCtD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—RAP1A—osteoporosis	0.000105	0.0033	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Estradiol—osteoporosis	0.000104	0.0029	CcSEcCtD
Fluoxymesterone—PRLR—Signaling Pathways—LRP6—osteoporosis	0.000103	0.00325	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—GAPDH—osteoporosis	0.000103	0.00325	CbGpPWpGaD
Fluoxymesterone—AR—uterus—osteoporosis	0.000102	0.0512	CbGeAlD
Fluoxymesterone—NR3C1—Transcription factor regulation in adipogenesis—TNF—osteoporosis	0.000101	0.00317	CbGpPWpGaD
Fluoxymesterone—ESR1—uterus—osteoporosis	0.0001	0.0503	CbGeAlD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—IL1B—osteoporosis	9.8e-05	0.00309	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—BMP2—osteoporosis	9.79e-05	0.00309	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—VDR—osteoporosis	9.73e-05	0.00307	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—osteoporosis	9.65e-05	0.00304	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—osteoporosis	9.58e-05	0.00302	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—ESR2—osteoporosis	9.42e-05	0.00297	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—IL6—osteoporosis	9.35e-05	0.00295	CbGpPWpGaD
Fluoxymesterone—Progesterone—SHBG—osteoporosis	9.24e-05	0.043	CrCbGaD
Fluoxymesterone—Headache—Estradiol—osteoporosis	8.88e-05	0.00247	CcSEcCtD
Fluoxymesterone—PRLR—Immune System—PSMA5—osteoporosis	8.84e-05	0.00279	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—PSMA2—osteoporosis	8.84e-05	0.00279	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CYP19A1—osteoporosis	8.78e-05	0.00277	CbGpPWpGaD
Fluoxymesterone—Testosterone—SHBG—osteoporosis	8.73e-05	0.0407	CrCbGaD
Fluoxymesterone—PRLR—Signaling Pathways—TLN1—osteoporosis	8.71e-05	0.00274	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	8.67e-05	0.00273	CbGpPWpGaD
Fluoxymesterone—Nausea—Estradiol—osteoporosis	8.42e-05	0.00234	CcSEcCtD
Fluoxymesterone—ESR1—Leptin signaling pathway—LEP—osteoporosis	8.28e-05	0.00261	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—ESR1—osteoporosis	8.23e-05	0.00259	CbGpPWpGaD
Fluoxymesterone—NR3C1—Transcription factor regulation in adipogenesis—IL6—osteoporosis	8.12e-05	0.00256	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	8.01e-05	0.00252	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—P4HB—osteoporosis	7.51e-05	0.00237	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—KL—osteoporosis	7.48e-05	0.00236	CbGpPWpGaD
Fluoxymesterone—NR3C1—uterus—osteoporosis	7.4e-05	0.0371	CbGeAlD
Fluoxymesterone—ESR1—Leptin signaling pathway—IRS1—osteoporosis	7.38e-05	0.00233	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—osteoporosis	7.32e-05	0.00231	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PTH—osteoporosis	7.3e-05	0.0023	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—RAP1A—osteoporosis	7.18e-05	0.00226	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—ESR2—osteoporosis	7.14e-05	0.00225	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CNR2—osteoporosis	7.12e-05	0.00224	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—KL—osteoporosis	7.01e-05	0.00221	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NFATC1—osteoporosis	7e-05	0.00221	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—DKK1—osteoporosis	6.95e-05	0.00219	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CYP19A1—osteoporosis	6.76e-05	0.00213	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—WNT1—osteoporosis	6.69e-05	0.00211	CbGpPWpGaD
Fluoxymesterone—ESR1—FOXM1 transcription factor network—MYC—osteoporosis	6.54e-05	0.00206	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—POMC—osteoporosis	6.52e-05	0.00206	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—FGA—osteoporosis	6.51e-05	0.00205	CbGpPWpGaD
Fluoxymesterone—ESR1—LKB1 signaling events—MYC—osteoporosis	6.41e-05	0.00202	CbGpPWpGaD
Fluoxymesterone—Testosterone—CYP19A1—osteoporosis	6.41e-05	0.0298	CrCbGaD
Fluoxymesterone—NR3C1—bone marrow—osteoporosis	6.28e-05	0.0315	CbGeAlD
Fluoxymesterone—Progesterone—ESR1—osteoporosis	6.24e-05	0.0291	CrCbGaD
Fluoxymesterone—Dexamethasone—CYP19A1—osteoporosis	6.2e-05	0.0289	CrCbGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	6.17e-05	0.00194	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—MYC—osteoporosis	6.08e-05	0.00192	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—BMP2—osteoporosis	6.05e-05	0.00191	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PTHLH—osteoporosis	6.05e-05	0.00191	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—FGB—osteoporosis	5.92e-05	0.00187	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—AGER—osteoporosis	5.88e-05	0.00185	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—ADCY5—osteoporosis	5.86e-05	0.00185	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—ESR1—osteoporosis	5.86e-05	0.00185	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—IL6—osteoporosis	5.74e-05	0.00181	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PSMA5—osteoporosis	5.72e-05	0.0018	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PSMA2—osteoporosis	5.72e-05	0.0018	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—TNF—osteoporosis	5.66e-05	0.00178	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—IRS1—osteoporosis	5.48e-05	0.00173	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—IRS2—osteoporosis	5.37e-05	0.00169	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CALCA—osteoporosis	5.33e-05	0.00168	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—IL1B—osteoporosis	5.28e-05	0.00166	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—LEP—osteoporosis	5.25e-05	0.00165	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IRS2—osteoporosis	5.13e-05	0.00162	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—osteoporosis	5.07e-05	0.0016	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—osteoporosis	5.02e-05	0.00158	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—IL6R—osteoporosis	5.01e-05	0.00158	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—U2AF1—osteoporosis	5e-05	0.00158	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	4.86e-05	0.00153	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—KL—osteoporosis	4.84e-05	0.00153	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—IRS2—osteoporosis	4.81e-05	0.00152	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—IRS1—osteoporosis	4.68e-05	0.00148	CbGpPWpGaD
Fluoxymesterone—ESR1—Validated nuclear estrogen receptor alpha network—MYC—osteoporosis	4.67e-05	0.00147	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IRS1—osteoporosis	4.48e-05	0.00141	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—MYC—osteoporosis	4.45e-05	0.0014	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—TGFB1—osteoporosis	4.44e-05	0.0014	CbGpPWpGaD
Fluoxymesterone—NR3C1—Endoderm Differentiation—TGFB1—osteoporosis	4.37e-05	0.00138	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—MYC—osteoporosis	4.34e-05	0.00137	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—IGF1—osteoporosis	4.34e-05	0.00137	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—TGFB1—osteoporosis	4.33e-05	0.00137	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—MYC—osteoporosis	4.28e-05	0.00135	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—TGFB1—osteoporosis	4.27e-05	0.00135	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—IRS1—osteoporosis	4.22e-05	0.00133	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IL6R—osteoporosis	4.21e-05	0.00133	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	4.2e-05	0.00132	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—IRS1—osteoporosis	4.2e-05	0.00132	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—ESR2—osteoporosis	3.98e-05	0.00125	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—IL6R—osteoporosis	3.94e-05	0.00124	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—osteoporosis	3.87e-05	0.00122	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—U2AF1—osteoporosis	3.85e-05	0.00121	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—IL1B—osteoporosis	3.81e-05	0.0012	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—osteoporosis	3.81e-05	0.0012	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—IL6R—osteoporosis	3.8e-05	0.0012	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—U2AF1—osteoporosis	3.79e-05	0.0012	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—ADCY5—osteoporosis	3.79e-05	0.00119	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—IL6—osteoporosis	3.74e-05	0.00118	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—RPL24—osteoporosis	3.71e-05	0.00117	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—SPP1—osteoporosis	3.67e-05	0.00116	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IRS2—osteoporosis	3.32e-05	0.00105	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—IL6—osteoporosis	3.27e-05	0.00103	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—LEP—osteoporosis	3.25e-05	0.00102	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	3.24e-05	0.00102	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—IL6—osteoporosis	3.22e-05	0.00101	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IL1B—osteoporosis	3.2e-05	0.00101	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—VDR—osteoporosis	3.16e-05	0.000995	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—ESR1—osteoporosis	3.1e-05	0.000977	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—ESR2—osteoporosis	3.06e-05	0.000966	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—MYC—osteoporosis	3.05e-05	0.000961	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—ESR2—osteoporosis	3.02e-05	0.000951	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IRS1—osteoporosis	2.9e-05	0.000913	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—IL1B—osteoporosis	2.89e-05	0.000912	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SOST—osteoporosis	2.89e-05	0.00091	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—RPL24—osteoporosis	2.86e-05	0.000902	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—IL6—osteoporosis	2.83e-05	0.000893	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—RPL24—osteoporosis	2.82e-05	0.000888	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—POMC—osteoporosis	2.79e-05	0.000879	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—TNF—osteoporosis	2.77e-05	0.000872	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IL6R—osteoporosis	2.72e-05	0.000857	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IGF1—osteoporosis	2.68e-05	0.000845	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CALCR—osteoporosis	2.61e-05	0.000823	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PTH1R—osteoporosis	2.61e-05	0.000823	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—TGFB1—osteoporosis	2.6e-05	0.00082	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	2.53e-05	0.000796	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	2.52e-05	0.000794	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—VDR—osteoporosis	2.43e-05	0.000767	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—TNF—osteoporosis	2.43e-05	0.000766	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—ESR1—osteoporosis	2.41e-05	0.00076	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—VDR—osteoporosis	2.4e-05	0.000755	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	2.35e-05	0.000742	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—MYC—osteoporosis	2.35e-05	0.00074	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—IL6—osteoporosis	2.23e-05	0.000704	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—PSMA2—osteoporosis	2.14e-05	0.000676	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—PSMA5—osteoporosis	2.14e-05	0.000676	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—TNF—osteoporosis	2.1e-05	0.000662	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MGLL—osteoporosis	2.07e-05	0.000654	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—LRP5—osteoporosis	2.02e-05	0.000638	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—IL6—osteoporosis	1.96e-05	0.000618	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	1.95e-05	0.000613	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	1.94e-05	0.000612	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—LRP6—osteoporosis	1.94e-05	0.00061	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—ESR2—osteoporosis	1.92e-05	0.000604	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IL6—osteoporosis	1.87e-05	0.000591	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—ESR1—osteoporosis	1.83e-05	0.000577	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	1.81e-05	0.000571	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—IL6—osteoporosis	1.76e-05	0.000554	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—IL6—osteoporosis	1.69e-05	0.000534	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—PSMA5—osteoporosis	1.65e-05	0.00052	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—PSMA2—osteoporosis	1.65e-05	0.00052	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TLN1—osteoporosis	1.64e-05	0.000515	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—PSMA2—osteoporosis	1.63e-05	0.000513	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—PSMA5—osteoporosis	1.63e-05	0.000513	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MYC—osteoporosis	1.61e-05	0.000508	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TGFB1—osteoporosis	1.61e-05	0.000507	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—VDR—osteoporosis	1.52e-05	0.000479	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—ESR2—osteoporosis	1.48e-05	0.000465	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—ESR2—osteoporosis	1.45e-05	0.000458	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—P4HB—osteoporosis	1.41e-05	0.000444	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PTH—osteoporosis	1.37e-05	0.000432	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—RAP1A—osteoporosis	1.35e-05	0.000425	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CNR2—osteoporosis	1.34e-05	0.000421	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NFATC1—osteoporosis	1.31e-05	0.000414	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—DKK1—osteoporosis	1.3e-05	0.000411	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—WNT1—osteoporosis	1.26e-05	0.000396	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—MYC—osteoporosis	1.25e-05	0.000396	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FGA—osteoporosis	1.22e-05	0.000385	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IL6—osteoporosis	1.21e-05	0.000382	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—VDR—osteoporosis	1.17e-05	0.000369	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—ESR1—osteoporosis	1.16e-05	0.000366	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—VDR—osteoporosis	1.15e-05	0.000363	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PTHLH—osteoporosis	1.14e-05	0.000358	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—BMP2—osteoporosis	1.14e-05	0.000358	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FGB—osteoporosis	1.11e-05	0.000351	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PSMA2—osteoporosis	1.07e-05	0.000338	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PSMA5—osteoporosis	1.07e-05	0.000338	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CALCA—osteoporosis	1e-05	0.000315	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—MYC—osteoporosis	9.67e-06	0.000305	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—MYC—osteoporosis	9.52e-06	0.0003	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—KL—osteoporosis	9.09e-06	0.000286	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—ESR1—osteoporosis	8.81e-06	0.000278	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ADCY5—osteoporosis	7.12e-06	0.000224	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SPP1—osteoporosis	6.89e-06	0.000217	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IRS2—osteoporosis	6.23e-06	0.000196	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—LEP—osteoporosis	6.09e-06	0.000192	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—MYC—osteoporosis	6.04e-06	0.00019	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IRS1—osteoporosis	5.44e-06	0.000171	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—POMC—osteoporosis	5.23e-06	0.000165	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IL6R—osteoporosis	5.11e-06	0.000161	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IGF1—osteoporosis	5.04e-06	0.000159	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—MYC—osteoporosis	4.65e-06	0.000147	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—MYC—osteoporosis	4.58e-06	0.000144	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MYC—osteoporosis	3.03e-06	9.54e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TGFB1—osteoporosis	3.02e-06	9.51e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IL6—osteoporosis	2.27e-06	7.17e-05	CbGpPWpGaD
